• ‘Simple’ NLP Tool Streamlines Metastatic Cancer Research

    Clinical Research News | Researchers at the Medical University of South Carolina (MUSC) are using a “super-simple” natural language processing (NLP) tool to streamline clinical research for metastatic brain cancer, a field where rapid advances in therapy are outpacing traditional methods of data analysis.

    Oct 21, 2025

  • The Scope of Things: Tackling the Deadlocks in Patient Recruitment

    Clinical Research News | Clinical trial recruitment has long been a hurdle in medical research, and despite decades of discussion, the obstacles are still standing, particularly in adapting marketing strategies to today’s digital world. On the latest episode of The Scope of Things, host Deborah Borfitz spoke with Christine Senn, senior vice president of site sponsor innovation at Advarra, about the challenges sites and sponsors face and offered some practical tactics for solving them.

    Oct 17, 2025

  • Anju, Clinical Trials Information Network Win Best of Show at SCOPE Europe 2025

    Bio-IT World | The SCOPE Europe 2025 Best of Show winners have been announced! This year, 22 finalists presented their products in the exhibit hall, and attendees voted for the most innovative and impactful technologies, tools, products, and solutions used by life sciences.

    Oct 16, 2025

  • SCOPE Europe 2025 Best of Show Entries

    Clinical Research News | It’s time to vote for the SCOPE Europe 2025 Best of Show awards! This year, there are 22 finalists that will be displaying their products in Barcelona. Attendees of SCOPE Europe are invited and encouraged to identify extraordinary innovative technologies used by life science professionals and to vote on the most impactful new products of the year.

    Oct 10, 2025

  • Out-of-the-Box CRA First ‘Agentic Teammate’ to Join Study Teams

    Clinical Research News | Clinical research associates (CRAs) may soon be working alongside an artificial intelligence (AI) agent offering relief from some of the drudgery of the job, including crunching data from a dozen or more data sources in search of meaningful insights and actionable information. Medable has just launched Agent Studio, the first agentic AI platform purpose-built for life sciences that comes with an out-of-the-box CRA agent.

    Oct 8, 2025

  • Unlocking New Pathways for Treating Recurrent Ovarian Cancer

    Clinical Research News | Recurrent ovarian cancer treatment has always had dismal responses because differences between cancer patients are not fully understood. To tackle this challenge, a team from the Department of Oncology of the Lausanne University Hospital and the Lausanne, Switzerland branch of the Ludwig Institute for Cancer Research conducted a large-scale clinical research study to provide insight into how immune and genomic signatures may finally guide more effective care.

    Oct 7, 2025

  • Clinical Trials Drive Innovation in Infant Gut Health

    Clinical Research News | In a food system that prioritizes profits and quantity over nutritional quality, most babies born today lack the gut microbes they need before kindergarten to train their immune system. Persephone Biome, a California-based biotech company, is tackling this issue with its latest product, the Daily Synergistic Synbiotic.

    Oct 2, 2025

  • Combining eCOA and Objective Digital Endpoints: Promise and Pitfalls

    Clinical Research News | The clinical research industry is awash in new data streams. With the rise of wearables, sensors, and smartphone-based assessments, objective digital measures are increasingly complementing traditional patient-reported outcomes. But should these endpoints be combined, or is it better to keep them separate? A recent SCOPE 365 ClinEco Connect session brought together experts and industry participants to wrestle with this question.

    Sep 30, 2025

  • nPhase Mixes Data, Evidence in One Platform, N-Power Medicine, VieCure Enter Partnership, More

    Clinical Research News | nPhase launches the first industry platform to harmonize real-world evidence and clinical trial data in one system; N-Power Medicine and VieCure have entered a strategic partnership; and more.

    Sep 25, 2025

  • Follow the Money: Adjustment Disorder Clinical Trial, Solving Trial Recruitment Failure, More

    Clinical Research News | Reunion Neuroscience will continue with its ongoing REKINDLE Phase 2 clinical trial in Adjustment Disorder (AjD) in cancer; Trially has launched Margo, an agentic AI solution that multiplies trial enrollment by converting patient matches into participants; and more.

    Sep 24, 2025

  • Paldara, Mayo Clinic Push Phage Therapy Toward First Human Trials

    Clinical Research News | Phage therapy, a treatment that uses viruses to fight bacterial infections, may finally be heading toward mainstream clinical practice. Paldara, a biotech startup, is developing a delivery platform that promises to stabilize and sustain bacteriophages and make phage therapy accessible for patients.

    Sep 23, 2025

  • Building Momentum: Strengthening Patient Retention in Clinical Trials

    Clinical Research News | In clinical research, keeping patients engaged throughout the course of a trial is not only a logistical goal but a scientific necessity. Retention ensures that datasets remain complete, representative, and reliable. High dropout rates, by contrast, mean gaps in data, higher costs to backfill participants, and extended timelines that frustrate everyone involved.

    Sep 19, 2025

  • Psilocybin Shows Potential as Candidate for Delayed Aging

    Clinical Research News | Psilocybin—the psychoactive compound found in “magic mushrooms”—has often been viewed in a negative light due to the reputation of psychedelics, even among experts. But new research suggests that the compound could have a role in slowing the aging process.

    Sep 16, 2025

  • Tackling Trial and Data Complexity in DCTs with Advanced Analytics and Machine Learning

    Clinical Research News | Advanced statistical and machine learning (ML) models offer new ways to cope with an evolving and increasingly complex clinical trial data landscape. It enables us to interrogate new, complex and raw data sources, perform complex data reviews, learn from past studies and process large volumes of data.

    Sep 12, 2025

  • The Scope of Things: A Global Movement to Cure Multiple Myeloma

    Clinical Research News | In this month’s episode of The Scope of Things podcast, Joseph Mikhael, chief medical officer of the International Myeloma Foundation (IMF), discusses how the Black Swan Research Initiative (BSRI), a global scientific alliance dedicated to finding a cure for multiple myeloma, and global collaborators are making strides in multiple myeloma research and prevention efforts.

    Sep 10, 2025

  • New Microbiome-Derived Proteins Trials for Chronic Disease Treatment

    Clinical Research News | The gut microbiome has long been recognized as a key influencer of human health, but most clinical efforts to translate that knowledge have revolved around broad dietary interventions, probiotics, or microbial metabolites. Now, a team of researchers in Denmark is taking a new route that focuses on specific bacterial proteins that may directly regulate human metabolism and advancing them into clinical testing.

    Sep 9, 2025

  • LLMs Transform Clinical Trial Data Analysis with Human-Level Accuracy

    Clinical Research News | A study presented at the American Association for Cancer Research (AACR) conference reveals that large language models (LLMs) can match human experts in identifying critical cancer progression events from electronic health records—a development with significant implications for clinical trials and personalized medicine.

    Sep 4, 2025

  • Many Trials Testing Psychedelics for Treating Substance Abuse Disorders

    Clinical Research News | A resurgence of research interest in psychedelics over the past 25 years might soon see compounds like psilocybin, otherwise known as “magic mushrooms,” finally having their day. In the clinical trial setting, dozens of studies are now underway testing psychedelics for the treatment of post-traumatic stress disorder (PTSD), depression, and, perhaps most commonly, substance abuse disorders (SUDs).

    Sep 2, 2025

  • Study Cancellations Undercut Site Viability, Stakeholders Say

    Clinical Research News | In an environment where clinical trial budgets are scrutinized and timelines compressed, the human and operational toll of cancelled studies poses a serious threat. It undercuts site stability, strains patient engagement, and jeopardizes future collaboration. A recent SCOPE 365 ClinEco Connect session convened industry veterans across sites, sponsors, and CROs to seek a solution.

    Aug 28, 2025

  • Follow the Money: Supplying Global Clinical Trials, Novel Next-Gen Biosensor, More

    Clinical Research News | ARTBIO plans to rapidly advance its manufacturing network infrastructure to supply global clinical trials and commercialization, as well as their pipeline of alpha radioligand therapies; Sava Technologies will accelerate regulatory approval and commercialization of its next-generation wearable; and more.

    Aug 27, 2025